Adial Pharmaceuticals Inc. (ADIL) — AI Analysis & Mentions

ADIL tumbled 19.9% on a 1-for-25 reverse stock split to maintain Nasdaq listing. Despite a clean balance sheet, profitability issues and volatile trading make this a high-risk bet. Buffett typically avoids such speculative situations, especially when the underlying business lacks a durable advantage or proven track record.